Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Burcon NutraScience Corp T.BU

Alternate Symbol(s):  BRCNF

Burcon NutraScience Corporation is a Canada-based technology company. The Company is engaged in the development of plant-based proteins for foods and beverages. The Company has a patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is involved in the production, sales, marketing and distribution of pulse protein ingredients, including Peazazz and Peazac pea proteins and its canola proteins, Supertein, Puratein and Nutratein (collectively, the Products). The Company's subsidiary is Burcon NutraScience (MB) Corp., which is engaged in the research and development.


TSX:BU - Post by User

Comment by Trendsetteron Feb 01, 2022 4:24pm
207 Views
Post# 34386827

RE:RE:RE:RE:Merit: “We anticipate to grow to four times the size.”

RE:RE:RE:RE:Merit: “We anticipate to grow to four times the size.”Groundskeeper for once a decent thought provoking post instead of the unintersting and negative Capitalraiser (aka fundmanager and Summer...does he own shares or not?)  

Regardless, I appreciate you thoughts but have a few comments and questions of you to add. 

I doubt the Q3 results will  be showing much in the way of revenue as its my understanding Merit were still trying to complete the commisioning process until mid December.  Would you agree?

I heard chat that any potential JV is up to a year away as the large CPG's move extremelly slowly and therefore any interest here would be after deep DD on BU's technology and proven product testing.

Unfortunately, Im thnking another down leg on disapointing news.

What makes you think that $4.50 is the number?   Is this simply the value of the Merit partnership or would your $4.50 buyout target include the remaining technology portfolio?


 
<< Previous
Bullboard Posts
Next >>